20 August 2026 – SAHPRA hereby reaffirms the safety of routine childhood vaccination used in South Africa based on ongoing evidence and monitoring. Vaccination remains one of the most effective and safest ways to protect the public against serious and potentially life-threatening vaccine-preventable diseases, which is...
Pretoria, 17 August 2026 – Tshwane University of Technology (TUT) Faculty of Science students at the Arcadia Campus filled the Science Hall to welcome the South African Health Products Regulatory Authority (SAHPRA) as part of its ongoing programme to engage university students and raise...
Pretoria, 16 August 2026 – The South African Health Products Regulatory Authority (SAHPRA) has initiated the recall of four batches of Enalapril 10mg Arya, a medicine commonly used to treat high blood pressure (hypertension), following the identification of out-of-specification results during post-marketing surveillance inspections. The recall...
Pretoria, 20 July 2026 – Approximately 200 pharmacy and science students at Rhodes University gathered at the University's Makhanda campus, formerly Grahamstown, on 9 July to explore careers in health product regulation during the South African Health Products Regulatory Authority's (SAHPRA) participation in the University's...
Pretoria, 08 July 2026 – The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS...
Pretoria, 25 June 2026 - Since its establishment in 2018, the South African Health Products Regulatory Authority has maintained a strong focus on patient safety as a central pillar of its mandate. In terms of the Medicines and Related Substances Act, 1965 (Act 101 of...
Pretoria, 03 June 2026 – The South African Health Products Regulatory Authority (SAHPRA) convened its quarterly stakeholder engagement session with “captains of industry” in Johannesburg on 14 May 2026. The meeting forms part of a structured programme of quarterly engagements that SAHPRA has maintained since...
Pretoria, 23 May 2026 – The South African Health Products Regulatory Authority (SAHPRA), in collaboration with the South African Pharmacy Council (SAPC), has intensified enforcement action against the unlawful manufacturing and distribution of unregistered GLP-1 and GIP medicines containing either Semaglutide, Tirzepatide, or a combination...
Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) today briefed members of the media on the recall of specific batches of Citro-Soda Regular products, reaffirming its commitment to protecting public health and ensuring the safety, quality, and efficacy of all...
Pretoria, 20 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) will brief the media on the recall of specific batches of Citro-Soda Regular following a potential contamination risk identified at the Adcock Ingram Clayville manufacturing facility in Johannesburg. The recall is limited to...
